Torrent Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Torrent Pharma - Not Just Healthcare But Lifecare
One of their notable products is RASAGILINE MESYLATE, with a corresponding US DMF Number 30600.
Remarkably, this DMF maintains an Active status since its submission on June 21, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 20, 2016, and payment made on June 16, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II